RNF41 protein could be a new therapeutic target against cirrhosis and liver inflammation

The RNF41 protein could be a new therapeutic target in the fight against two chronic liver diseases: cirrhosis and liver inflammation.

Related Keywords

United States ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Pedro Melgar Lesmes ,Megan Craig ,Department Of Biomedicine ,Biomedical Research Networking Center ,Health Sciences Of The University Barcelona ,Pii Sunyer Biomedical Research Institute ,Massachusetts Institute Of Technology ,Science Translational Medicine ,Health Sciences ,Sunyer Biomedical Research Institute ,Digestive Diseases ,Massachusetts Institute ,Cirrhosis ,Inflammation ,Liver ,Ebiomedicine ,Hronic ,Drugs ,Ibrosis ,Immune System ,Liver Disease ,Acrophage ,Medicine ,Anoparticles ,Protein ,Research ,